FLT3 Ligand Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FLT3 Ligand Immunotherapy, covering 2024-06-06 to 2024-06-06. Get the full timeline:
Most recent: Clinical Trial Update: FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer [Phase 2]